Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
No results were found for the filter!
EB-0156
Item number: TGM-T63170-100mg
Description: EB-0156, an N-substituted valerian derivative, is a potent inhibitor of ER alpha-glucosidase (alpha-Glu) I and II with IC50 values of 0.0479 and <0.001 µM, respectively, exhibiting broad-spectrum antiviral activity and potential for drug discovery against existing and emerging viruses. Target: Others
| MW: | 480.51 D |
From 1,440.00€
*
ATM Inhibitor-3
Item number: TGM-T63171-100mg
Description: ATM Inhibitor-3 is a potent and selective inhibitor of ATM (IC50: 0.71 nM). ATM Inhibitor-3 inhibits the PI3K kinase family and exhibits good metabolic stability. Target: Others
| MW: | 480.53 D |
From 1,440.00€
*
LPA5 antagonist 2
Item number: TGM-T63172-100mg
Description: LPA5 antagonist 2 (compound 65) is a highly water-soluble LPA5 antagonist that significantly reduces nociception and can be used to study inflammatory and neuropathic pain. Target: Others
| MW: | 480.55 D |
From 1,440.00€
*
BTK-IN-8
Item number: TGM-T63173-100mg
Description: BTK-IN-8 is a potent, selective, peripheral covalent BTK inhibitor with an IC50 value of 0.22 nM and a Kd value of 0.91 nM. BTK-IN-8 exhibits good potency in whole blood CD69 cells with an IC50 value of 0.029 µM. Target: Others
| MW: | 480.6 D |
From 1,440.00€
*
CARM1-IN-3 dihydrochloride
Item number: TGM-T63180-100mg
Description: CARM1-IN-3 dihydrochloride (compound 17b) is a potent and selective coactivator-associated arginine methyltransferase inhibitor, targeting CARM1 with an IC50 of 0.07 µM and exhibiting minimal activity on CARM3 (IC50 > 25 µM). Target: Others
| MW: | 481.46 D |
From 1,374.00€
*
BTK-IN-15
Item number: TGM-T63182-100mg
Description: BTK-IN-15 is a novel, orally active Bruton's tyrosine kinase (BTK) inhibitor that inhibits BTK (IC50: 0.7 nM). BTK-IN-15 induces apoptosis in cancer cells and has good kinase selectivity and anti-tumour activity. Target: Others
| MW: | 481.52 D |
From 1,440.00€
*
EGFR-IN-47
Item number: TGM-T63185-100mg
Description: EGFR-IN-47 is a potent, orally active inhibitor of EGFRL858R/T790M/C797S (IC50: 0.01 µM). EGFR-IN-47 is capable of blocking the cell cycle and inducing apoptosis. EGFR-IN-47 has potential for NSCLC studies. Target: Others
| MW: | 481.64 D |
From 1,440.00€
*
Cav 3.2 inhibitor 1
Item number: TGM-T63186-100mg
Description: Cav 3.2 inhibitor 1 is a T-type calcium channel inhibitor with low binding affinity for the dopamine receptor (D2 receptor) and can be used in studies of physical and visceral pain. Target: Others
| MW: | 481.67 D |
From 1,440.00€
*
EGFR/BRAF-IN-1
Item number: TGM-T63189-100mg
Description: EGFR/BRAF-IN-1, a 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivative, is a potent inhibitor of EGFR/BRAF, inhibiting BRAFV600E (IC50:45 nM) and cancer cell proliferation (GI50=35 nM), with good antioxidant effect. Target: Others
| MW: | 481.97 D |
From 1,440.00€
*
Lp-PLA2-IN-10
Item number: TGM-T63192-100mg
Description: Lp-PLA2-IN-10 is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), formerly known as platelet-activating factor acetylhydrolase (PAF-AH). This enzyme catalyzes the hydrolysis of lipoprotein lipids or phospholipids. The compound has research potential in neurodegenerative diseases...
| MW: | 482.36 D |
From 1,440.00€
*
DS17701585
Item number: TGM-T63196-100mg
Description: DS17701585 is an orally active, selective inhibitor of EP300 and CBP, capable of acting on CBP (IC50: 0.040 µM), EP300 (IC50: 0.15 µM), H3K27 (IC50: 0.45 µM) and SOX2 (IC50: 0.7 µM), and can be used to study cancer. Target: Others
| MW: | 482.55 D |
From 1,440.00€
*
Dalpiciclib hydrochloride
Item number: TGM-T63199-100mg
Description: Dalpiciclib (SHR-6390) hydrochloride is a highly selective, orally active CDK4/6 inhibitor with IC50 values of 12.4 nM and 9.9 nM, respectively, acting as an antitumor agent in breast and esophageal squamous cell carcinomas. Target: Others
| MW: | 483.01 D |
From 1,412.00€
*